Utidelone-based therapy in metastatic solid tumors after failure of standard therapies: A prospective, multicenter, single-arm trial

被引：0
|
作者：
Zhang, J. [1 ]
Liu, Z. [1 ]
Ding, H. [2 ]
Ma, L. [1 ]
Lu, H. [3 ]
Shi, Y. [4 ]
Lin, F. [5 ]
Zheng, L. [6 ]
Wang, M. [7 ]
Qiao, G. [1 ]
Deng, Z. [1 ]
Yu, L. [1 ]
Zhang, Y. [1 ]
Yuan, Y. [1 ]
Lin, H. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, Shanghai Gen Hosp, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Oncol, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Oncol, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China
[7] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.200
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
66P
引用
收藏
页码：S1491 / S1491
页数：1
相关论文
共 50 条
  • [21] A multicenter single-arm pilot study of ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors: the RamuNET trial
    Krug, S.
    Michl, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 49 - 49
  • [22] Efficacy and safety of utidelone in previously treated patients with advanced or metastatic soft tissue sarcomas (HX-SARC02): A prospective, single-arm, phase II study
    Jiang, Y.
    Fu, Y.
    Liu, J.
    Wang, B.
    Li, M.
    Zhang, H.
    Deng, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S1046 - S1046
  • [23] Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
    Sebastian Krug
    Thomas Kegel
    Thomas M. Gress
    Anja Rinke
    Leonidas Apostolidis
    Henning Jann
    Alexander König
    Dieter Hörsch
    Jörg Schrader
    Thomas J. Ettrich
    Michael Richter
    Jörg Steighardt
    Patrick Michl
    BMC Cancer, 21
  • [24] A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors
    Gatti-Mays, Margaret E.
    Tschernia, Nicholas P.
    Strauss, Julius
    Madan, Ravi A.
    Karzai, Fatima H.
    Bilusic, Marijo
    Redman, Jason
    Sater, Houssein Abdul
    Floudas, Charalampos S.
    Toney, Nicole J.
    Donahue, Renee N.
    Jochems, Caroline
    Marte, Jennifer L.
    Francis, Deneise
    McMahon, Sheri
    Lamping, Elizabeth
    Cordes, Lisa
    Schlom, Jeffrey
    Gulley, James L.
    ONCOLOGIST, 2023, : 364e217
  • [25] A PROSPECTIVE MULTICENTER SINGLE-ARM CLINICAL TRIAL OF BEVACIZUMAB FOR PATIENTS WITH SURGICALLY UNTREATABLE SYMPTOMATIC BRAIN RADIATION NECROSIS
    Miyatake, S.
    Furuse, M.
    Nonoguchi, N.
    Kuroiwa, T.
    Nakatani, E.
    Kurisu, S.
    Nakagawa, Y.
    NEURO-ONCOLOGY, 2016, 18 : 73 - 73
  • [26] A prospective, multicenter, single-arm clinical trial of PD-1 inhibitors in combination with radiotherapy and GM-CSF, sequentially followed by IL-2 (PRaG 2.0) therapy in advanced refractory solid tumors
    Xing, Pengfei
    Yang, Jiabao
    Kong, Yuehong
    Xu, Meiling
    Wang, Jian
    Wang, Jianshe
    Ma, Yifu
    Zhang, Liyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Pemetrexed monotherapy as salvage treatment in metastatic colorectal cancer patients who failed standard chemotherapy: A phase II single-arm prospective trial.
    Lim, Sung Won
    Cho, Jangho
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Seung Tae
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [28] Avatrombopag for the treatment of immune checkpoint inhibitor/targeted therapy-related thrombocytopenia in patients with hepatocellular carcinoma: A prospective, multicenter, single-arm trial
    Wang, Y-S.
    Wang, J-Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S1482 - S1483
  • [29] Toripalimab plus anlotinib in patients with recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm phase 2 trial (TORAL)
    Zhang, Yuchen
    Zou, Qihua
    Zhao, Baitian
    Su, Ning
    Li, Zhihua
    Wang, Xicheng
    Liu, Panpan
    Tian, Xiaopeng
    Fang, Xiaojie
    Cai, Jun
    Li, Lirong
    Liu, Yingxian
    Xia, Yi
    Cai, Qingqing
    CELL REPORTS MEDICINE, 2024, 5 (12)
  • [30] First-Line Treatment of Locally Advanced or Metastatic Pulmonary Lymphoepitheliomalikecarcinoma: A Multicenter, Single-Arm, Phase II Trial
    Zhou, C.
    Lin, X.
    Li, S.
    Sun, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S96 - S97
12345